PR85883

NANJING, China, Sept. 30, 2020 /Xinhua=KYODO JBN/--

From September 19 to 21, the 11th China (Taizhou) International Medical Expo

was held at the China Medical City Exhibition Center. With the theme of

"Development Trends in the Medical and Health Industry under the Epidemic", the

current medical expo held 23 special events and attracted participants from 21

countries and regions. Nearly 800 pharmaceutical companies participated in the

exhibition. After 11 years of professional accumulation, this year's expo

presents three "higher" characteristics: a higher degree of internationalization,

a higher degree of specialization, and a higher degree of professionalization. This time,

the expo also innovatively set up an online cloud exhibition, providing services

such as online conferences, VR exhibitions, and enterprise docking, and building

an integrated online and offline communication platform.

During the expo, China Medical City released the latest preferential policies

for investment promotion, involving a total of 25 preferential policies in 7

major sectors, covering the R&D, production, sales and application of the

pharmaceutical health industry. Relying on the advantages of abundant financial

support, complete talent support policies, professional full-process services,

and complete supporting facilities, China Medical City has built a first-class

industrial ecosystem, and initially formed antibodies, vaccines, diagnostic

reagents, high-performance medical equipment and a batch of characteristic

industrial clusters such as new pharmaceutical preparations and special medical

formula foods. More than 1,200 pharmaceutical companies, including 13

world-renowned multinational pharmaceutical companies such as Nestle and

AstraZeneca, have taken root for development. The expo attracted 24 major

projects from home and abroad to sign and settle down, with a total investment

of 19.755 billion yuan, covering many fields such as antibodies, vaccines, and

high-end medical devices.

The Taizhou Pharmaceutical High-tech Zone continues to promote the provincial

and ministerial joint construction system to provide support for the

development of China Medical City. Pharmaceutical companies have successively

won the "National" brand such as the National Innovative Park, the New Vaccine

and Specific Diagnostic Reagent Industry Cluster, and the National New Drug and

Special Industrialization Demonstration Base. Currently in the critical period

of "second entrepreneurship", Taizhou Pharmaceutical High-tech Zone will follow

the path of industrialization, specialization, capitalization and internationalization,

to speed up the construction to become "China's No. 1 and World Famous" Medical City.

Source: Taizhou China Medical City

Image Attachments Links:

   Link: http://asianetnews.net/view-attachment?attach-id=373137 

   Caption: The scene of China (Taizhou) International Medical Expo